The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...

As weight loss jabs like Ozempic and Wegovy become ever more popular, doctors are growing increasingly concerned about their ...

WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...

One in eight Americans use GLP-1 weight-loss drugs, but are they getting the real thing? Novo Nordisk's dramatic exit from a popular platform reveals the hidden risks of online prescriptions.

JPMorgan said Eli Lilly is enrolling about 500,000 new obesity drug patients per month, and maintains more than 60% share in ...

Abbott Laboratories is a dividend growth machine that's known for consistency. AbbVie's dividend has more than quadrupled ...

Eli Lilly (NYSE:LLY) drew attention on Friday after JPMorgan reiterated its bullish stance on the stock, raising its price ...

The deadliest disease in the U.S. is one of the most preventable.

IF you thought we left diet culture back in the 1990s, think again. Toxic ideas about bodies and weight are creeping back ...

The human exposome is the environmental equivalent of the human genome, and there's a project in the works to map it.  It's a huge project that needs to take into account our lifestyles, cultures, ...